SEOUL– JW Pharmaceutical on Thursday announced that it will sell stock to raise 4.4 billion won(US$3.1 million). The proceeds from the stock sale will be used mainly to finance its operations.
According to a regulatory filing, the company will issue 142,920 preferred shares at a price of 30,871 won per share. The stock will be sold to the investors that the firm designated.
Source: Yonhap News Agency